IP Library Granted Patent US 10,813,576
Granted Patent B2
US 10,813,576 · App. 16/691,382 · Granted Oct 27, 2020

Analyte sensor

Inventors: Mark C. Brister (Encinitas, CA); Steve Masterson (Encinitas, CA); John Nolting (Poway, CA); James R. Petisce (San Diego, CA); Jack Pryor (San Diego, CA); Sean Saint (San Diego, CA); Peter C. Simpson (San Diego, CA); Vance Swanson (San Diego, CA); Matthew D. Wightlin (San Diego, CA)
Assignee: DexCom, Inc.
A61B5/14532A61B5/0002A61B5/0004A61B5/05A61B5/1411A61B5/1473A61B5/1486A61B5/1495A61B5/14503A61B5/14507A61B5/14514A61B5/14546A61B5/14735A61B5/14865A61B5/6801A61B5/6833A61B5/6848A61B5/6849A61B5/68335A61B5/72A61B17/3468A61B5/14A61B5/145A61B5/1468A61B5/150022A61B2017/3492A61B2560/0223A61B2560/045A61B2562/18A61M5/14244A61M5/1723A61M2005/1585Y02A90/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,813,576
App. No.
16/691,382
Granted
Oct 27, 2020
Kind
B2
Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims (29)

1. A system for measuring an analyte concentration in a host, the system comprising:

a sensor system comprising:

a first package comprising:

a transcutaneous analyte sensor configured to measure a signal indicative of analyte concentration in the host; and

electrical contacts operably connected to the transcutaneous analyte sensor, wherein the electrical contacts are configured to form an operable connection to sensor electronics prior to sensor use;

wherein the transcutaneous analyte sensor is associated with an alphanumeric code, and

wherein the first package is labeled with the alphanumeric code; and

a second package comprising:

sensor electronics configured to be operably connected to the transcutaneous analyte sensor through the electrical contacts when the sensor electronics are operably connected to the transcutaneous analyte sensor by the host prior to sensor use, wherein the sensor electronics also comprise an RF module for wireless communications, wherein the sensor electronics are associated with the alphanumeric code, and

wherein the second package is labeled with the alphanumeric code;

wherein the sensor electronics are configured to communicate with a receiver that comprises:

a processor configured to receive sensor information from the sensor electronics and to process the sensor information received from the sensor electronics, and

a display configured to display an estimated analyte concentration value associated with the sensor information; and

wherein the sensor electronics are configured to transmit information associated with the alphanumeric code to the receiver.

2. The system of claim 1 , wherein the transcutaneous analyte sensor comprises a transcutaneous sensor having an in vivo portion and an ex vivo portion.

3. The system of claim 2 , wherein the electrical contacts are operably connected to the ex vivo portion of the transcutaneous analyte sensor.

4. The system of claim 1 , wherein the first package comprises a contact holder.

5. The system of claim 4 , wherein the first package comprises a seal at least partially disposed over the contact holder.

6. The system of claim 5 , wherein the seal at least partially surrounds the ex vivo portion of the transcutaneous analyte sensor.

7. The system of claim 5 , wherein the seal at least partially surrounds the electrical contacts.

8. The system of claim 1 , wherein the transcutaneous analyte sensor is radiation sterilized.

9. The system of claim 8 , wherein the sensor electronics are not radiation sterilized.

10. The system of claim 1 , additionally comprising an applicator.

11. The system of claim 10 , wherein one or both of the sensor first component and the second component sensor electronics is coupled to the applicator.

12. The system of claim 11 , wherein the first package additionally comprises a mounting unit operably connectable to the transcutaneous analyte sensor.

13. The system of claim 12 , wherein the mounting unit is operably connectable to the applicator.

14. The system of claim 12 , wherein the applicator and the mounting unit are configured to be operably connected by the host prior to sensor use.

15. The system of claim 14 , wherein the mounting unit and the sensor electronics are configured to be operably connected by the host prior to sensor use.

16. The system of claim 1 , wherein the alphanumeric code is a serial number that identifies both the transcutaneous analyte sensor and the sensor electronics.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: MASTERSON, STEVE; SIMPSON, PETER; WIGHTLIN, MATTHEW D.; PRYOR, JACK; SWANSON, VANCE
To: DEXCOM, INC.
Reel/Frame 052301/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: BRISTER, MARK; PETISCE, JAMES R.; WOO, KUM MING; SAINT, SEAN; NOLTING, JOHN
To: DEXCOM, INC.
Reel/Frame 051848/0435 →
Continuity (6)
Continuation 16674610 · Nov 5, 2019
Continuation 16392521 · Apr 23, 2019
Continuation 14590483 · Jan 6, 2015
Continuation 13909962 · Jun 4, 2013
Continuation 11360262 · Feb 22, 2006
Related Publication 20200085351A1 · Mar 19, 2020
Cited By (6)
US 1,130,752 US 12,187,480 US 12,279,865 US 12,490,919 US 12,642,456 US 12,666,543